G A A b st ra ct s and 4 mood-related questions. Emma provided correct answers. Emma v1 tested general knowledge and nutrition. Emma v2 featured more questions, 2 levels of difficulty, and was categorized by General, Anatomy & Testing, Medications, and Nutrition. We obtained information on sex, age group (10-14yr vs. 15-18yr), IBD-type, medications, and history of surgery. Feedback from patients and clinicians was obtained in both versions. Results: Sites 1 and 2 tested Emma v1 between February-August, and May-August 2013, respectively. Emma v2 was tested from November 1-November 23, 2013, and May-August 2013, respectively. A total of 58 patients (59% male, 67% Crohn's) played Emma v1, while 33 patients (64% male, 58% Crohn's) played Emma v2. Seven patients played both versions; only 7 patients played EMMA v2 at site 2. In Emma v1, 82% of disease-related questions were answered correctly. The mean mood scores for sadness (1.3, SD=0.69, range 1-4), anxiety (1.4, SD=0.9, range 1-5), energy (2.6, SD=1.5, range 1-5), and IBD-related QOL (2.0, SD= 1.5, range 1-5) indicated generally good functioning. In Emma v2, 61.1% of total knowledge questions were answered correctly, while percentages in General, Anatomy/Testing, Medications, and Nutrition were 66.8%, 65.8%, 74.5%, and 79.6%, respectively. Neither age nor IBD-type was correlated with disease knowledge. Of patients with difficult questions, 58.4% were answered correctly. The mean mood scores for sadness (1.6, SD=1.03, range 1-4), anxiety (2.2, SD=1.2, range 1-5), energy (2.2, SD=1.3, range 1-5), and IBD-related QOL (1.9, SD=1.3, range 1-5) indicated generally good functioning. Four patients were referred for mental health support. Conclusions: Pediatric patients with IBD need more diseaserelated education. The Emma ipad game has the potential to evaluate and teach gaps in knowledge, assess emotional functioning, and increase patient engagement.